NCT06165094

Brief Summary

The goal of this observational study is to learn about in health conditions of ESCC. The main question\[s\] it aims to answer are: •Lymph node metastasis(LNM) in cervical paraesophageal or supraclavicular which influence OS more. Participants will describe the main status quo after surgery Researchers will compare Lymph node metastasis(LNM) in cervical paraesophageal and supraclavicular to see if dead.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
14.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 3, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
Last Updated

December 11, 2023

Status Verified

December 1, 2023

Enrollment Period

14.9 years

First QC Date

December 3, 2023

Last Update Submit

December 8, 2023

Conditions

Keywords

oesophageal squamous cell carcinoma; cervical paraesophageal lymph node metastasis; supraclavicular lymph node metastasis; lymphadenectomy; esophagectomy

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    OS was calculated from the month and year of surgery until the time of death or the last follow-up in March 2021.

    2009.01.01-2017.12.30

Study Arms (2)

Diagnosed with supraclavicular LNM

There was no intervention(s) in any group

Diagnosed with paraesophageal LNM

There was no intervention(s) in any group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Demographic and pathologic data, including gender, age, pathological T stage, pathological N stage, 8th tumor-node-metastasis (TNM) stage, tumor location, tumor grade, lymphovascular invasion, perineural invasion, LNM, cervical paraesophageal LNM, supraclavicular LNM, and radical resection, were collected from the Sichuan Cancer Hospital and Institute Esophageal Cancer Case Management (SCH-ECCM) database.

You may qualify if:

  • patients who had undergone esophagectomy and
  • patients who exhibited LNM in the supraclavicular region.

You may not qualify if:

  • tumor location outside the thoracic region,
  • pathological examination results confirming the presence of non-squamous cell carcinoma, - patients with both cervical paraesophageal LNM and supraclavicular LNM, or
  • those with missing required data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sichaun cancer hospital

Chengdu, Sichuan, 610041, China

Location

MeSH Terms

Conditions

Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesCarcinoma, Squamous CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms, Squamous Cell

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 3, 2023

First Posted

December 11, 2023

Study Start

January 1, 2009

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

December 11, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations